Role of Beta2 Agonists in Respiratory Medicine with Particular Attention to Novel Patents and Effects on Endocrine System and Immune Response

被引:1
作者
Larocca, Nancy E. [1 ]
Moreno, Dolores [1 ]
Garmendia, Jenny, V [2 ,3 ]
De Sanctis, Juan B. [2 ,3 ]
机构
[1] Univ Cent Venezuela, Dept Pathol & Physiopathol, Expt Med Inst, Fac Med, Caracas, Venezuela
[2] Univ Cent Venezuela, Inst Immunol, Fac Med, Dept Clin Immunol, Caracas, Venezuela
[3] Univ Cent Venezuela, Inst Immunol, Fac Med, Dept Basic Immunol, Caracas, Venezuela
关键词
Adrenergic receptor agonists; asthma; beta 2 adrenergic receptor; COPD; genetic polymorphism; immune response; LABA; lymphocytes; macrophages; neutrophils;
D O I
10.2174/187221411797265908
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Beta adrenergic receptors are very important in respiratory medicine. Traditionally, the stimulation of beta adrenergic receptors by beta2-agonists is commonly used for giving bronchodilation in chronic airflow obstruction However; the wide distribution of these receptors in cells and tissues other than airway smooth muscle suggests that beta agonists should offer other beneficial effects in respiratory disease. Recent studies have shown the importance of these receptors in the modulation of endocrine and immune system that affect respiratory function and may decrease therapy effectiveness in asthma and chronic obstructive pulmonary disease. New patented compound and uses have provided new insights in future therapeutics of respiratory diseases in which genetic, endocrine and immune response should be considered.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 59 条
[1]  
Alcaraz L., 2009, Phenethanolamine derivatives as beta 2 adrenoreceptor agonists., Patent No. [US20090029958, 20090029958]
[2]   Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol [J].
Basu, Kaninika ;
Palmer, Colin N. A. ;
Tavendale, Roger ;
Lipworth, Brian J. ;
Mukhopadhyay, Somnath .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (06) :1188-1194
[3]   Overweight, obesity, and incident asthma - A meta-analysis of prospective epidemiologic studies [J].
Beuther, David A. ;
Sutherland, E. Rand .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (07) :661-666
[4]   Clenbuterol Induces Cardiac Myocyte Hypertrophy via Paracrine Signalling and Fibroblast-derived IGF-1 [J].
Bhavsar, Pankaj K. ;
Brand, Nigel J. ;
Felkin, Leanne E. ;
Luther, Pradeep K. ;
Cullen, Martin E. ;
Yacoub, Magdi H. ;
Barton, Paul J. R. .
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2010, 3 (06) :688-695
[5]  
Bozung K.-H., 2010, Combination of drugs Medicament compositions containing anticholinergically-effective compounds and betamimetics, Patent No. [US20100197719, 20100197719]
[6]  
Brambilla G., 2011, Patent No. [US20110081301, 20110081301]
[7]   β2-adrenoceptor agonists: current and future direction [J].
Cazzola, Mario ;
Calzetta, Luigino ;
Matera, Maria Gabriella .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (01) :4-17
[8]   The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD [J].
Cazzola, Mario ;
Molimard, Mathieu .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (04) :257-267
[9]   Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma [J].
Chung, L. P. ;
Waterer, G. ;
Thompson, P. J. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (03) :312-326
[10]  
Dessing C., 2008, Use of agonists and antagonists of beta adrenoceptors for treating arterial disease., Patent No. [US20080221203, 20080221203]